Does OSELTAMIVIR Cause Activated partial thromboplastin time prolonged? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Activated partial thromboplastin time prolonged have been filed in association with OSELTAMIVIR (oseltamavir phosphate). This represents 0.5% of all adverse event reports for OSELTAMIVIR.
60
Reports of Activated partial thromboplastin time prolonged with OSELTAMIVIR
0.5%
of all OSELTAMIVIR reports
60
Deaths
55
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From OSELTAMIVIR?
Of the 60 reports, 60 (100.0%) resulted in death, 55 (91.7%) required hospitalization, and 53 (88.3%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSELTAMIVIR. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does OSELTAMIVIR Cause?
Vomiting (1,561)
Off label use (1,538)
Nausea (1,055)
No adverse event (810)
Drug ineffective (688)
Dyspnoea (582)
Diarrhoea (553)
Hallucination (502)
Influenza (443)
Rash (439)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which OSELTAMIVIR Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
OSELTAMIVIR vs OSILODROSTAT
OSELTAMIVIR vs OSIMERTINIB
OSELTAMIVIR vs OSPEMIFENE
OSELTAMIVIR vs OSPHENA
OSELTAMIVIR vs OVINE DIGOXIN IMMUNE FAB